VBI Vaccines Announces Pricing of $18 Million Public Offering and $3 Million Concurrent Registered Direct Offering

portfolio company news

Jul 6

Written by MacDougall Creative

MacDougall Creative https://www.macbiocom.com

Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock

VBI Vaccines and Brii Biosciences Expand Hepatitis B Partnership To Address Both Prevention and Treatment in License and Collaboration Agreements for up to $437 Million Plus Royalties